ASX Share rice
Sun 09 Aug 2020 - 05:34:pm (Sydney)

PBP Share Price

PROBIOTEC LIMITEDPBPPharmaceuticals, Biotechnology & Life Sciences

PBP Company Information

Name:

Probiotec Limited

Sector:

Healthcare

Industry:

Drug Manufacturers—Specialty & Generic

GIC Industry:

Pharmaceuticals

GIC Sub Industry:

Pharmaceuticals

Address:

83 Cherry Lane Laverton North VIC Australia 3026

Phone:

61 3 9278 7555

CEO, MD & Exec. Director:

Mr. Wesley Stringer B.Comm, LLB (Hons), CPA

CFO, Company Sec. & Financial Controller:

Mr. Jared Stringer

Chief Operating Officer:

Ms. Julie McIntosh

Gen. Mang. of Accounting:

Mr. Alan Hong

Gen. Mang. of Marketing:

Mr. Dustin Stringer

Company Overview:

Probiotec Limited manufactures, markets, and distributes a range of prescription and over-the-counter pharmaceuticals, complementary medicines, and specialty ingredients in Australia and internationally. The company is involved in the contract manufacturing of solid dose tablets, capsules, and caplets; liquids, powders, creams and ointments, and lotions and gels; and tablet coatings. It also provides packaging options, including blister packs, bottles, sachets, tubs, and tubes; analytical and stability testing services; new product formulation and production trials, and ongoing research and development services; and packaging options for human and animal nutrition products, as well as manufactures and exports a range of nutraceuticals and functional ingredient raw materials. Probiotec Limited was founded in 1997 and is headquartered in Laverton North, Australia.

PBP Share Price Information

Shares Issued:

74.78M

Market Capitalisation:

$149.18M

Dividend per Share:

$0.04

Ex Dividend Date:

2020-03-03

Dividend Yield:

2.01%

Revenue (TTM):

$90.17M

Revenue Per Share (TTM):

$1.43

Earnings per Share:

$0.175

Profit Margin:

-0.01

Operating Margin (TTM):

$0.09

Return On Assets (TTM):

$0.04

Return On Equity (TTM):

$0.08

Quarterly Revenue Growth (YOY):

0.335

Gross Profit(TTM):

$25.75M

Diluted Earnings Per Share (TTM):

$-0.014

QuarterlyEarnings Growth(YOY):

-0.948

PBP CashFlow Statement

CashFlow Date:

2019-06-30

Investments:

$30.06M

Change To Liabilities:

$-3,413,537

Total Cashflow From Investing Activities:

$30.06M

Net Borrowings:

$-8,592,943

Net Income:

$11.33M

Total Cash From Operating Activities:

$-4,385,322

Depreciation:

$2.98M

Dividends Paid:

$-5,066,814

Change To Inventory:

$-1,694,445

Change To Account Receivables:

$-2,310,216

Sale Purchase Of Stock:

$-5,743,070

Capital Expenditures:

$12.51M

PBP Income Statement

Income Date:

2019-06-30

Income Before Tax:

$4.99M

Net Income:

$11.33M

Gross Profit:

$25.75M

Operating Income:

$6.50M

Interest Expense:

$1.85M

Income Tax Expense:

$0.92M

Total Revenue:

$79.09M

Total Operating Expenses:

$19.25M

Cost Of Revenue:

$53.35M

PBP Balance Sheet

Balance Sheet Date:

2019-06-30

Intangible Assets:

$9.25M

Total Liabilities:

$56.52M

Total Stockholder Equity:

$49.85M

Other Current Liabilities:

$2.55M

Total Assets:

$106.37M

Common Stock:

$33.61M

Other Current Assets:

$5.78M

Retained Earnings:

$15.65M

Other Liabilities:

$11.09M

Good Will:

$8.17M

Other Assets:

$7.65M

Cash:

$8.84M

Total Current Liabilities:

$19.18M

Short-Term Debt:

$1.84M

Property - Plant & Equipment:

$34.23M

Net Tangible Assets:

$32.43M

Total Current Assets:

$47.07M

Long-Term Debt:

$3.23M

Net Receivables:

$19.48M

Short-Term Investments:

$59.30M

Inventory:

$13.25M

Accounts Payable:

$9.38M

Non Currrent Assets (Other):

$16.40M

Short-Term Investments:

$59.30

Non Current Liabilities Total:

$37.34M

PBP Share Price History

PBP News

11 Jul, 2020
The big shareholder groups in Probiotec Limited (ASX:PBP) have power over the company. Large companies usually have...
19 May, 2020
For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...
23 Apr, 2020
Wes Stringer has been the CEO of Probiotec Limited (ASX:PBP) since 2015. This analysis aims first to contrast CEO...
26 Mar, 2020
It might be of some concern to shareholders to see the Probiotec Limited (ASX:PBP) share price down 14% in the last...
28 Feb, 2020
Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is...
06 Feb, 2020
How far off is Probiotec Limited (ASX:PBP) from its intrinsic value? Using the most recent financial data, we'll take...
15 Jan, 2020
Dividend paying stocks like Probiotec Limited (ASX:PBP) tend to be popular with investors, and for good reason - some...
12 Dec, 2019
Today, we'll introduce the concept of the P/E ratio for those who are learning about investing. We'll apply a basic...
16 Nov, 2019
For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...
19 Oct, 2019
Readers hoping to buy Probiotec Limited (ASX:PBP) for its dividend will need to make their move shortly, as the stock...
08 Oct, 2019
We think all investors should try to buy and hold high quality multi-year winners. While not every stock performs...
02 Sep, 2019
Wes Stringer became the CEO of Probiotec Limited (ASX:PBP) in 2015. First, this article will compare CEO compensation...
13 Aug, 2019
One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will...

PBP Dividend Payments

EX-Date Dividend Amount
2010-02-25$0.0150
2010-08-30$0.0200
2016-09-02$0.0150
2017-03-20$0.0050
2017-09-04$0.0150
2018-03-19$0.0075
2018-09-04$0.0200
2018-11-06$0.0500
2019-02-28$0.0100
2019-10-23$0.0250
2020-03-02$0.0150

PBP Dividends (last 6 Years)